| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
ATYR sits in the Biotechnology industry within the Health Care sector, so this activity is best read against the sector's broader insider trend.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Dir | 779.1K | $386.7K | - | |
| CEO | 153.6K | $149.9K | - | |
| CFO | 37.3K | $36.4K | - | |
| Other | 33.1K | $32.3K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Sep 2, 2020 | Clarke John K | Director | Sell | 7,360 | $4.01 | $29,512.60 | -6.2% | |
| Aug 27, 2020 | Clarke John K | Director | Sell | 7,640 | $4.15 | $31,700.80 | -6.1% | |
| Jun 19, 2020 | Broadfoot Jill Marie63 | Chief Financial Officer | Buy | 1,850 | $4.22 | $7,807.00 | +25.3% | |
| Jun 19, 2020 | Shukla Sanjay66 | President and CEO | Buy | 6,000 | $4.27 | $25,620.00 | +464.8% | |
| May 20, 2020 | Schimmel Paul51 | Director | Sell | 8,447 | $3.64 | $30,738.63 | -1.9% | |
| May 20, 2020 | Denyes Nancy75 | General Counsel | Sale+OE | 322 | $3.62 | $1,165.64 | -10.5% | |
| Feb 10, 2020 | Schimmel Paul51 | Director | Buy | 254,000 | $4.25 | $1,079,500.00 | +138.4% | |
| Feb 7, 2020 | Broadfoot Jill Marie63 | Chief Financial Officer | Sale+OE | 375 | $4.03 | $1,511.25 | -5.0% | |
| Feb 7, 2020 | Shukla Sanjay66 | President and CEO | Sale+OE | 745 | $4.03 | $3,002.35 | -36.6% | |
| May 17, 2019 | Krueger Nancy75 | General Counsel | Sale+OE | 4,651 | $0.45 | $2,093.42 | -15.5% |